Employees
~50
Stage
Commercial
Modalities
Autologous cell therapyBioengineered tissue

Stability Biologics General Information

Provider of processed human tissue and bone products for surgical, spine and orthopedics applications. Products include structural/particulate bone, tendons/ligaments, structural allografts, demineralized bone matrix (DBM) and skin products.

Contact Information

Website
Primary Industry
Biotech
Corporate Office
Nashville, Tennessee
United States

Drug Pipeline

Physio
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Stability Biologics's pipeline data

Book a demo

Key Partnerships

MiMedx (acquired by in 2016)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Stability Biologics Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Stability Biologics's complete valuation and funding history, request access »